How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
On the evening of July 10, AI investor Matt Shumer posted a terse, furious message to X: GPT-5.6 Sol had just accidentally deleted nearly all the files on his Mac ...
XDA Developers on MSN
My NAS isn't my server — that's why my homelab survives every experiment I throw at it
The dumbest device in my homelab is the smartest choice.
Investor's Business Daily on MSN
AI stocks: Will self-improving models decide who wins superintelligence race?
Self-improving models are reshaping the AI race as OpenAI, Anthropic, Google and others pursue superintelligence.
Learn the important Racket concepts with practical examples, from functions and recursion to macros, contracts, streams, and ...
Scientists have unveiled a new fabrication technique for the ultra-clean manufacturing of 2D heterostructures—materials just ...
Cathie Wood's Ark Genomic Revolution ETF owns $50 million worth of Recursion Pharmaceuticals stock.
The US AI research company Anthropic has become known for building powerful AI models while simultaneously warning about ...
Sixtyfour CEO Saarth Shah explains how his company built AI research agents around rigorous evaluation systems rather than language model fluency, creating verification infrastructure that proves ...
It is tempting to picture UALink as a clean line between two accelerators: requests enter one side, responses emerge from the other. The abstraction is useful — but it conceals almost everything that ...
ThreatsDay Bulletin covers fraud arrests, supply-chain attacks, phishing, cloud hijacking, ransomware, Windows flaws, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results